scispace - formally typeset
K

Kirk H. Packo

Researcher at Rush University Medical Center

Publications -  40
Citations -  6480

Kirk H. Packo is an academic researcher from Rush University Medical Center. The author has contributed to research in topics: Visual acuity & Retinal detachment. The author has an hindex of 18, co-authored 40 publications receiving 5986 citations. Previous affiliations of Kirk H. Packo include Rush University.

Papers
More filters
Journal ArticleDOI

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

TL;DR: People older than 55 years should have dilated eye examinations to determine their risk of developing advanced AMD and those with extensive intermediate size drusen, at least 1 large druse, noncentral geographic atrophy in 1 or both eyes, or advanced AMD or vision loss due to AMD in 1 eye should consider taking a supplement of antioxidants plus zinc.
Journal ArticleDOI

Evaluation of Grid Pattern Photocoagulation for Macular Edema in Central Vein Occlusion: The Central Vein Occlusion Study Group M Report

John G. Clarkson, +121 more
- 01 Oct 1995 - 
TL;DR: In this article, the efficacy of macular grid photocoagulation in preserving or improving central visual acuity in eyes with macular edema due to central vein occlusion was evaluated.
Journal ArticleDOI

The Age-Related Eye Disease Study (AREDS): Design Implications AREDS Report No. 1

TL;DR: The AREDS design, including the study rationale and operational structure, and the approach adopted to combine, for two diseases, clinical trials with a natural history study are described.
Journal ArticleDOI

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins c and e and beta carotene for age-related cataract and vision loss: AREDS report no. 9

TL;DR: Use of a high-dose formulation of vitamin C, vitamin E, and beta carotene in a relatively well-nourished older adult cohort had no apparent effect on the 7-year risk of development or progression of age-related lens opacities or visual acuity loss.
Journal ArticleDOI

The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa.

TL;DR: The observation of retinal visual improvement in areas far from the implant site suggests a possible generalized neurotrophic-type rescue effect on the damaged retina caused by the presence of the ASR.